488 related articles for article (PubMed ID: 31444548)
1. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
2. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
[TBL] [Abstract][Full Text] [Related]
3. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
[TBL] [Abstract][Full Text] [Related]
5. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
[TBL] [Abstract][Full Text] [Related]
7. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
Winawer MR; Griffin NG; Samanamud J; Baugh EH; Rathakrishnan D; Ramalingam S; Zagzag D; Schevon CA; Dugan P; Hegde M; Sheth SA; McKhann GM; Doyle WK; Grant GA; Porter BE; Mikati MA; Muh CR; Malone CD; Bergin AMR; Peters JM; McBrian DK; Pack AM; Akman CI; LaCoursiere CM; Keever KM; Madsen JR; Yang E; Lidov HGW; Shain C; Allen AS; Canoll PD; Crino PB; Poduri AH; Heinzen EL
Ann Neurol; 2018 Jun; 83(6):1133-1146. PubMed ID: 29679388
[TBL] [Abstract][Full Text] [Related]
8. Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies.
Ferri L; Menghi V; Licchetta L; Dimartino P; Minardi R; Davì C; Di Vito L; Cifaldi E; Zenesini C; Gozzo F; Pelliccia V; Mariani V; de Spelorzi YCC; Gustincich S; Seri M; Tassi L; Pippucci T; Bisulli F
Epilepsy Behav; 2024 Apr; 153():109716. PubMed ID: 38508103
[TBL] [Abstract][Full Text] [Related]
9. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
[TBL] [Abstract][Full Text] [Related]
10. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
Sarnat HB; Flores-Sarnat L
Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
[TBL] [Abstract][Full Text] [Related]
11. Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical Dyslamination.
Park SM; Lim JS; Ramakrishina S; Kim SH; Kim WK; Lee J; Kang HC; Reiter JF; Kim DS; Kim HH; Lee JH
Neuron; 2018 Jul; 99(1):83-97.e7. PubMed ID: 29937275
[TBL] [Abstract][Full Text] [Related]
12. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
[TBL] [Abstract][Full Text] [Related]
13. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
Baulac S; Ishida S; Marsan E; Miquel C; Biraben A; Nguyen DK; Nordli D; Cossette P; Nguyen S; Lambrecq V; Vlaicu M; Daniau M; Bielle F; Andermann E; Andermann F; Leguern E; Chassoux F; Picard F
Ann Neurol; 2015 Apr; 77(4):675-83. PubMed ID: 25623524
[TBL] [Abstract][Full Text] [Related]
14. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
15. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.
Arai A; Saito T; Hanai S; Sukigara S; Nabatame S; Otsuki T; Nakagawa E; Takahashi A; Kaneko Y; Kaido T; Saito Y; Sugai K; Sasaki M; Goto Y; Itoh M
Brain Res; 2012 Aug; 1470():89-97. PubMed ID: 22759905
[TBL] [Abstract][Full Text] [Related]
16. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE.
Elziny S; Crino PB; Winawer M
Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137
[TBL] [Abstract][Full Text] [Related]
17. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy.
Ribierre T; Deleuze C; Bacq A; Baldassari S; Marsan E; Chipaux M; Muraca G; Roussel D; Navarro V; Leguern E; Miles R; Baulac S
J Clin Invest; 2018 Jun; 128(6):2452-2458. PubMed ID: 29708508
[TBL] [Abstract][Full Text] [Related]
18. Unilateral holohemispheric central nervous system lesions associated with medically refractory epilepsy in the pediatric population: a retrospective series of hemimegalencephaly and Rasmussen's encephalitis.
Wang DD; Benkli B; Auguste KI; Garcia PA; Sullivan J; Barkovich AJ; Chang EF; Tihan T
J Neurosurg Pediatr; 2014 Dec; 14(6):573-84. PubMed ID: 25303156
[TBL] [Abstract][Full Text] [Related]
19. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
20. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.
Lee JH; Huynh M; Silhavy JL; Kim S; Dixon-Salazar T; Heiberg A; Scott E; Bafna V; Hill KJ; Collazo A; Funari V; Russ C; Gabriel SB; Mathern GW; Gleeson JG
Nat Genet; 2012 Jun; 44(8):941-5. PubMed ID: 22729223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
